Company
Akura Medical
Akura Medical is a medical technology company dedicated to addressing venous thromboembolism (VTE).
Also known as Akura Medical, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- clinical research organizations, private clinics, and hospitals
- Legal name
- Akura Medical, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Our flagship product, the Katana™ Thrombectomy System, is poised to redefine pulmonary embolism (PE) treatment standards by enabling enhanced removal of diverse clot types more efficiently.
Funding snapshot
- Total raised
- $94.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series C, $53M2025-12-01
Funding rounds
- Series C
- $53M2025-12-01, Company stated
- Round, 2025
- $51.4M2025-11-12, SEC form D sold, 20 investors
- Round, 2023
- $18.4M2023-09-26, SEC form D sold, 27 investors
- Round, 2021
- $25M2021-12-21, SEC form D sold, 59 investors
Products
- Hardware
- Katana Thrombectomy System
Loading relationship preview